{"filing":{"accession_number":"0001828316-26-000033","cik":"0001828316","ticker":"PHAR","company_name":"Pharming Group N.V.","form":"6-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"a2026hy1pressrelease.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828316/000182831626000033/a2026hy1pressrelease.htm"},"events":[{"id":21926,"run_id":19796,"accession_number":"0001828316-26-000033","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a press release disclosing Pharming's second quarter and first half 2026 financial results, including revenues, operating profit/loss, and earnings per share. The document explicitly states \"Pharming reports second quarter and first half 2026 financial results\" and furnishes consolidated financial statements (income statement, balance sheet, segment information). The company also revises full-year 2026 guidance downward by US$30 million in revenues, which is material to investors' assessment of the registrant's financial performance and outlook.","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-07-30","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":21705,"accession_number":"0001828316-26-000033","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release disclosing Pharming's second quarter and first half 2026 financial results, including revenues, operating profit/loss, and earnings per share. The document explicitly states \"Pharming reports second quarter and first half 2026 financial results\" and furnishes consolidated financial statements (income statement, balance sheet, segment information). The company also revises full-year 2026 guidance downward by US$30 million in revenues, which is material to investors' assessment of the registrant's financial performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-30T10:13:37.133011+00:00","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-07-30"}]}